Antimicrobial resistance

Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million

Thursday, April 8, 2021 - 1:00pm

This includes a cash payment of approximately $714 million (600 million) for Mobidiags equity, and net debt of approximately $81 million.

Key Points: 
  • This includes a cash payment of approximately $714 million (600 million) for Mobidiags equity, and net debt of approximately $81 million.
  • Mobidiag develops and markets PCR (polymerase chain reaction)-based tests for acute care conditions such as gastrointestinal and respiratory infections, antimicrobial resistance management, and healthcare associated infections.
  • The Amplidiag and Novodiag platforms are automated instruments that deliver rapid turnaround times ranging from 50 minutes to two hours.
  • Mobidiag generated approximately $42 million (35 million) of revenue in calendar 2020.

A new report finds waterways near industrial farms in Canada could be a public health threat

Wednesday, April 7, 2021 - 2:56pm

TORONTO, April 7, 2021 /CNW/ - Public waterways next to industrial farms in Manitoba contain antibiotic resistance genes (ARGs) that are dangerous to public health says a report from the global charity World Animal Protection.

Key Points: 
  • TORONTO, April 7, 2021 /CNW/ - Public waterways next to industrial farms in Manitoba contain antibiotic resistance genes (ARGs) that are dangerous to public health says a report from the global charity World Animal Protection.
  • If action is not taken, in future, routine procedures like caesarean sections or cancer treatments could become dangerous worldwide.
  • The report found that industrial farms could be discharging superbugs into the wider environment as a result of pig waste being spread on fields and leeching into groundwater and public waterways.
  • In Manitoba, the presence of ARGs was evaluated from samples collected in November 2020 from publicly accessible spaces upstream and downstream of eight industrial pig farms.

Cūrza and the University of Florida Expand Collaboration to Include Bacterial Biothreats with DTRA Award

Thursday, April 1, 2021 - 1:42pm

SALT LAKE CITY, April 1, 2021 /PRNewswire/ --Crza Global, LLC (Crza) announced today that The Institute for Therapeutic Innovation (ITI) at the University of Florida has been awarded a $75M contract from the Defense Threat Reduction Agency (DTRA) in partnership with Crza.

Key Points: 
  • SALT LAKE CITY, April 1, 2021 /PRNewswire/ --Crza Global, LLC (Crza) announced today that The Institute for Therapeutic Innovation (ITI) at the University of Florida has been awarded a $75M contract from the Defense Threat Reduction Agency (DTRA) in partnership with Crza.
  • This program is aimed at the development of Crza's CZ-02 platform of antibiotics for the treatment of drug-resistant bacterial infections.
  • The CZ-02 platform represents a novel class of antibacterial agents with a unique mode of action.
  • Chad Testa, Ph.D., Vice President of Research at Crza will serve as Principal Investigator (PI) for Crza.

Worldwide Antibiotics Industry to 2026 - Featuring Pfizer, Bayer and Novartis Among Others

Tuesday, March 30, 2021 - 3:00pm

The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.

Key Points: 
  • The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
  • Presently, the demand for beta-lactam and beta-lactamase inhibitors class of antibiotics is more among healthcare providers.
  • The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases.
  • Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market.

Sepsis Alliance Launches POWER the AMRevolution, a National Initiative to Educate About the Risks of Antimicrobial Resistance and Steps to End Superbugs

Monday, March 29, 2021 - 1:00pm

As part of the POWER the AMRevolution initiative, Sepsis Alliance fielded a global survey to assess understanding of antimicrobial resistance around the world.

Key Points: 
  • As part of the POWER the AMRevolution initiative, Sepsis Alliance fielded a global survey to assess understanding of antimicrobial resistance around the world.
  • According to the survey results, nearly 50 percent of adults are unaware of the term "antimicrobial resistance."
  • Sepsis is one of the biggest health risks related to antimicrobial resistance.
  • To learn more about the dangers of antimicrobial resistance, sepsis, and the steps that can help end superbugs, visit http://www.endsuperbugs.org .

Novo Holdings REPAIR Impact Fund Announces Second Global Call for New Investment Proposals to Fight AMR

Monday, March 29, 2021 - 8:00am

COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).

Key Points: 
  • COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).
  • This is the EUR135 (USD 165) million REPAIR Impact Fund's sixth call for investment proposals since it was set up in 2018, and second global call.
  • To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis.
  • Aleks Engel, Partner at Novo Holdings and Director of the REPAIR Impact Fund, said: "AMR is very much the 'other' raging pandemic in addition to the all-pervasive COVID-19 crisis.

Novo Holdings REPAIR Impact Fund Announces Second Global Call for New Investment Proposals to Fight AMR

Monday, March 29, 2021 - 8:00am

COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).

Key Points: 
  • COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).
  • This is the EUR135 (USD 165) million REPAIR Impact Fund's sixth call for investment proposals since it was set up in 2018, and second global call.
  • To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis.
  • Aleks Engel, Partner at Novo Holdings and Director of the REPAIR Impact Fund, said: "AMR is very much the 'other' raging pandemic in addition to the all-pervasive COVID-19 crisis.

Global Antibiotics Market (2020 to 2026) - by Action Mechanism, Drug Class and Region - ResearchAndMarkets.com

Friday, March 26, 2021 - 12:14pm

The "Global Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
  • Presently, the demand for beta-lactam and beta-lactamase inhibitors class of antibiotics is more among healthcare providers.
  • Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market.

Viva! inspires MPs to urge UK Government to 'ban factory farming'

Thursday, March 25, 2021 - 12:01am

Factory farming is responsible for mass animal suffering, the rise of antimicrobial resistance, and the spread of potentially lethal diseases, the MPs warned.

Key Points: 
  • Factory farming is responsible for mass animal suffering, the rise of antimicrobial resistance, and the spread of potentially lethal diseases, the MPs warned.
  • In the UK, there are 1,674 operational factory farms, with almost 800 of those classed as megafarms.
  • As a result some one billion animals in the UK are exposed to factory farming methods each year.
  • "We strongly urge the Government to listen to Parliament and the will of the people, and outlaw the abhorrent practice of factory farming in the UK for good."

Preparing for the Next Pandemic Requires New, Effective Antibiotic Treatments to Fight Infection

Wednesday, March 17, 2021 - 2:00pm

As we mark one-year of the global COVID-19 pandemic, the widespread impact of infectious disease has become all too clear.

Key Points: 
  • As we mark one-year of the global COVID-19 pandemic, the widespread impact of infectious disease has become all too clear.
  • While discussions around infectious disease have advanced considering the current pandemic, critical steps are needed to prepare for future pandemics.
  • The Partnership to Fight Infectious Disease (PFID) is working to motivate action on ending one such threat: Antimicrobial Resistance (AMR).
  • For more information about the Partnership to Fight Infectious Disease, visit www.fightinfectiousdisease.org , on Twitter @ThePFID and LinkedIn .